• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
17β-Estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelin.17β-雌二醇和雌激素受体 α 通过 BMPR2 和 apelin 保护肺动脉高压患者的右心功能。
J Clin Invest. 2021 Mar 15;131(6). doi: 10.1172/JCI129433.
2
Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.雌二醇改善重度血管增殖性肺动脉高压大鼠的右心室功能:内源性和外源性性激素的作用
Am J Physiol Lung Cell Mol Physiol. 2015 May 1;308(9):L873-90. doi: 10.1152/ajplung.00006.2015. Epub 2015 Feb 20.
3
Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.Bmpr2 突变大鼠表现出肺动脉高压的肺和心脏特征。
Circulation. 2019 Feb 12;139(7):932-948. doi: 10.1161/CIRCULATIONAHA.118.033744.
4
17β-estradiol preserves right ventricular function in rats with pulmonary arterial hypertension: an echocardiographic and histochemical study.17β-雌二醇对肺动脉高压大鼠右心室功能的保护作用:一项超声心动图和组织化学研究
Int J Cardiovasc Imaging. 2019 Mar;35(3):441-450. doi: 10.1007/s10554-018-1468-0. Epub 2018 Oct 22.
5
17β-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension.17β-雌二醇介导重度肺动脉高压雌性大鼠右心室功能对急性剧烈运动的更好适应。
Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L375-88. doi: 10.1152/ajplung.00132.2016. Epub 2016 Jun 10.
6
Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle.骨形态发生蛋白受体2型突变右心室脂质蓄积的机制
Am J Respir Crit Care Med. 2016 Sep 15;194(6):719-28. doi: 10.1164/rccm.201507-1444OC.
7
Reverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertension.雌激素逆转重度肺动脉高压时右心室结构和细胞外基质重塑。
J Appl Physiol (1985). 2012 Jul;113(1):149-58. doi: 10.1152/japplphysiol.01349.2011. Epub 2012 May 24.
8
Oestrogen receptor alpha in pulmonary hypertension.肺动脉高压中的雌激素受体α
Cardiovasc Res. 2015 May 1;106(2):206-16. doi: 10.1093/cvr/cvv106. Epub 2015 Mar 12.
9
Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension.联合使用 STAT3 抑制剂增强 SERCA2a 诱导的 BMPR2 表达并抑制肺动脉高压。
Int J Mol Sci. 2021 Aug 24;22(17):9105. doi: 10.3390/ijms22179105.
10
Estrogen receptor-α prevents right ventricular diastolic dysfunction and fibrosis in female rats.雌激素受体-α可预防雌性大鼠右心室舒张功能障碍和纤维化。
Am J Physiol Heart Circ Physiol. 2020 Dec 1;319(6):H1459-H1473. doi: 10.1152/ajpheart.00247.2020. Epub 2020 Oct 16.

引用本文的文献

1
Sex differences in pulmonary (arterial) hypertension: does it matter?肺动脉高压中的性别差异:这重要吗?
Curr Opin Pulm Med. 2025 Sep 1;31(5):411-428. doi: 10.1097/MCP.0000000000001197. Epub 2025 Jul 23.
2
Addressing Sex as a Biological Variable in Preclinical Models of Lung Disease: An Official American Thoracic Society Research Statement.将性别作为肺部疾病临床前模型中的生物学变量来考量:美国胸科学会官方研究声明
Am J Respir Crit Care Med. 2025 Aug;211(8):1346-1368. doi: 10.1164/rccm.202506-1361ST.
3
Signaling pathways and targeted therapy for pulmonary hypertension.肺动脉高压的信号通路与靶向治疗
Signal Transduct Target Ther. 2025 Jul 1;10(1):207. doi: 10.1038/s41392-025-02287-8.
4
Transcriptional Signatures of the Right Ventricle in End-Stage Heart Failure.终末期心力衰竭时右心室的转录特征
Pulm Circ. 2025 Apr 24;15(2):e70090. doi: 10.1002/pul2.70090. eCollection 2025 Apr.
5
Redox regulation of lung endothelial PERK, unfolded protein response (UPR) and proliferation via NOX1: Targeted inhibition as a potential therapy for PAH.通过NOX1对肺内皮细胞PERK、未折叠蛋白反应(UPR)和增殖的氧化还原调节:靶向抑制作为肺动脉高压的潜在治疗方法。
Redox Biol. 2025 May;82:103554. doi: 10.1016/j.redox.2025.103554. Epub 2025 Feb 19.
6
Sex-dependent Pathophysiology and Therapeutic Considerations in Right Heart Disease.右心疾病中的性别依赖性病理生理学及治疗考量
Can J Cardiol. 2025 Jun;41(6):1038-1053. doi: 10.1016/j.cjca.2025.02.034. Epub 2025 Mar 5.
7
An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management Strategies.深入洞察新冠病毒相关心血管疾病的临床、细胞和分子因素,以确定新型疾病生物标志物、药物靶点和临床管理策略。
Arch Microbiol Immunol. 2024;8(3):290-308. doi: 10.26502/ami.936500177. Epub 2024 Jul 19.
8
Decoding the enigmatic estrogen paradox in pulmonary hypertension: delving into estrogen metabolites and metabolic enzymes.解读肺动脉高压中神秘的雌激素悖论:深入探究雌激素代谢产物和代谢酶
Cell Mol Biol Lett. 2024 Dec 18;29(1):155. doi: 10.1186/s11658-024-00671-w.
9
Association of Male Sex With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Cohort.在通过肺血管疾病表型组学队列重新定义肺动脉高压研究中,男性性别与肺动脉高压患者右心室功能较差及生存率较低之间的关联。
CHEST Pulm. 2024 Sep;2(3). doi: 10.1016/j.chpulm.2024.100046. Epub 2024 Mar 11.
10
Molecular remodeling in comorbidities associated with heart failure: a current update.与心力衰竭相关的合并症中的分子重构:最新进展。
Mol Biol Rep. 2024 Oct 26;51(1):1092. doi: 10.1007/s11033-024-10024-7.

本文引用的文献

1
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.鉴定长链非编码 RNA H19 作为肺动脉高压右心衰竭的新生物标志物和治疗靶点。
Circulation. 2020 Oct 13;142(15):1464-1484. doi: 10.1161/CIRCULATIONAHA.120.047626. Epub 2020 Jul 23.
2
Sex Differences in Right Ventricular-Pulmonary Arterial Coupling in Pulmonary Arterial Hypertension.肺动脉高压中右心室-肺动脉耦联的性别差异
Am J Respir Crit Care Med. 2020 Oct 1;202(7):1042-1046. doi: 10.1164/rccm.202003-0807LE.
3
Transcriptional and Cellular Diversity of the Human Heart.人类心脏的转录和细胞多样性。
Circulation. 2020 Aug 4;142(5):466-482. doi: 10.1161/CIRCULATIONAHA.119.045401. Epub 2020 May 14.
4
Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.Bmpr2 突变大鼠表现出肺动脉高压的肺和心脏特征。
Circulation. 2019 Feb 12;139(7):932-948. doi: 10.1161/CIRCULATIONAHA.118.033744.
5
Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update.肺动脉高压中心脏右心室和肺循环的病理生理学:更新。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01900-2018. Print 2019 Jan.
6
Single-nucleus transcriptomic survey of cell diversity and functional maturation in postnatal mammalian hearts.单细胞转录组分析揭示了哺乳动物心脏出生后细胞多样性和功能成熟的特征。
Genes Dev. 2018 Oct 1;32(19-20):1344-1357. doi: 10.1101/gad.316802.118. Epub 2018 Sep 25.
7
Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.研究环境下心功能右心室评估:知识空白与前进道路。美国胸科学会官方研究声明。
Am J Respir Crit Care Med. 2018 Aug 15;198(4):e15-e43. doi: 10.1164/rccm.201806-1160ST.
8
Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension.超越雌激素:对肺动脉高压激素谱进行更广泛评估
Eur Respir J. 2018 Jun 28;51(6). doi: 10.1183/13993003.01058-2018. Print 2018 Jun.
9
Short-Term Hemodynamic Effects of Apelin in Patients With Pulmonary Arterial Hypertension.阿哌利肽对肺动脉高压患者的短期血流动力学影响
JACC Basic Transl Sci. 2018 Mar 28;3(2):176-186. doi: 10.1016/j.jacbts.2018.01.013. eCollection 2018 Apr.
10
PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation.过氧化物酶体增殖物激活受体γ激动剂吡格列酮通过脂肪酸氧化逆转肺动脉高压并预防右心衰竭。
Sci Transl Med. 2018 Apr 25;10(438). doi: 10.1126/scitranslmed.aao0303.

17β-雌二醇和雌激素受体 α 通过 BMPR2 和 apelin 保护肺动脉高压患者的右心功能。

17β-Estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelin.

机构信息

Department of Medicine, Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Pulmonary Hypertension Research Group, Institute Universitaire de Cardiologie et de Pneumologie de Québec - Université Laval, Quebec City, Quebec, Canada.

出版信息

J Clin Invest. 2021 Mar 15;131(6). doi: 10.1172/JCI129433.

DOI:10.1172/JCI129433
PMID:33497359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7968046/
Abstract

Women with pulmonary arterial hypertension (PAH) exhibit better right ventricular (RV) function and survival than men; however, the underlying mechanisms are unknown. We hypothesized that 17β-estradiol (E2), through estrogen receptor α (ER-α), attenuates PAH-induced RV failure (RVF) by upregulating the procontractile and prosurvival peptide apelin via a BMPR2-dependent mechanism. We found that ER-α and apelin expression were decreased in RV homogenates from patients with RVF and from rats with maladaptive (but not adaptive) RV remodeling. RV cardiomyocyte apelin abundance increased in vivo or in vitro after treatment with E2 or ER-α agonist. Studies employing ER-α-null or ER-β-null mice, ER-α loss-of-function mutant rats, or siRNA demonstrated that ER-α is necessary for E2 to upregulate RV apelin. E2 and ER-α increased BMPR2 in pulmonary hypertension RVs and in isolated RV cardiomyocytes, associated with ER-α binding to the Bmpr2 promoter. BMPR2 is required for E2-mediated increases in apelin abundance, and both BMPR2 and apelin are necessary for E2 to exert RV-protective effects. E2 or ER-α agonist rescued monocrotaline pulmonary hypertension and restored RV apelin and BMPR2. We identified what we believe to be a novel cardioprotective E2/ER-α/BMPR2/apelin axis in the RV. Harnessing this axis may lead to novel RV-targeted therapies for PAH patients of either sex.

摘要

女性肺动脉高压 (PAH) 患者的右心室 (RV) 功能和存活率优于男性;然而,其潜在机制尚不清楚。我们假设,17β-雌二醇 (E2) 通过雌激素受体 α (ER-α),通过依赖 BMPR2 的机制上调促收缩和促生存肽 Apelin,从而减轻 PAH 诱导的 RV 衰竭 (RVF)。我们发现,RVF 患者和适应性(而非适应性)RV 重构大鼠的 RV 匀浆中 ER-α 和 Apelin 的表达减少。E2 或 ER-α 激动剂处理后,RV 心肌细胞中的 Apelin 丰度在体内或体外增加。使用 ER-α 缺失或 ER-β 缺失小鼠、ER-α 功能丧失突变大鼠或 siRNA 的研究表明,ER-α 是 E2 上调 RV Apelin 所必需的。E2 和 ER-α 增加了肺动脉高压 RV 中的 BMPR2 和分离的 RV 心肌细胞中的 BMPR2,与 ER-α 结合到 Bmpr2 启动子有关。BMPR2 是 E2 介导的 Apelin 丰度增加所必需的,BMPR2 和 Apelin 都是 E2 发挥 RV 保护作用所必需的。E2 或 ER-α 激动剂挽救了野百合碱肺动脉高压,并恢复了 RV Apelin 和 BMPR2。我们确定了我们认为在 RV 中存在的一种新的心脏保护 E2/ER-α/BMPR2/Apelin 轴。利用这个轴可能会为男女 PAH 患者带来新的 RV 靶向治疗方法。